"EFFECTIVENESS OF DIPEPTIDIL PEPTIDASA-4 INHIBITORS COMPARED TO OTHER ORAL HYPOGLYCAEMIC AGENTS IN THE TREATMENT OF TYPE II DIABETES MELLITUS".
DOI:
https://doi.org/10.33064/51lm20223196Keywords:
Type 2 Diabetes mellitus, hypoglycemic agents, sitagliptin, metformin, glycosylated hemoglobinAbstract
To date, metformin is the oral hypoglycemic agent par excellence in patients with type 2 diabetes mellitus (T2DM), either in monotherapy or in combined therapies with other drugs. However, there are other families of drugs that help regulate blood glucose levels, such as the dipeptidyl peptidase-4 inhibitors that have shown promising results in the control of patients with this disease.
Downloads
Download data is not yet available.
Metrics
Metrics Loading ...
Published
2022-09-02
How to Cite
Hernández González, K. C., & Navarro Aparicio, L. D. (2022). "EFFECTIVENESS OF DIPEPTIDIL PEPTIDASA-4 INHIBITORS COMPARED TO OTHER ORAL HYPOGLYCAEMIC AGENTS IN THE TREATMENT OF TYPE II DIABETES MELLITUS". Lux Médica, 17(51). https://doi.org/10.33064/51lm20223196
Issue
Section
ARTÍCULO DE REVISIÓN
License
Copyright (c) 2022 Katya Cecilia Hernández González, Luis Daniel Navarro Aparicio
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Lux Médica está bajo una licencia de Creative Commons Reconocimiento-NoComercial-Compartir Igual 4.0 Internacional.
